Renovaro Inc. Faces Delisting Concerns

Ticker: LNAI · Form: 8-K · Filed: Aug 6, 2025 · CIK: 1527728

Renovaro Inc. 8-K Filing Summary
FieldDetail
CompanyRenovaro Inc. (LNAI)
Form Type8-K
Filed DateAug 6, 2025
Risk Levelhigh
Sentimentbearish

Sentiment: bearish

Topics: delisting, compliance, regulatory

TL;DR

Renovaro Inc. might get delisted - big trouble ahead.

AI Summary

Renovaro Inc. filed an 8-K on August 6, 2025, to report its notice of delisting or failure to satisfy a continued listing rule. The company was formerly known as Renovaro Biosciences Inc. and Enochian Biosciences Inc. The filing indicates potential issues with meeting stock exchange listing requirements.

Why It Matters

This filing signals potential financial distress or non-compliance with exchange rules, which could lead to the company's stock being removed from trading.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards is a severe indicator of financial instability or significant operational issues.

Key Players & Entities

  • RENOVARO INC. (company) — Registrant
  • Renovaro Biosciences Inc. (company) — Former company name
  • Enochian Biosciences Inc. (company) — Former company name
  • August 6, 2025 (date) — Date of earliest event reported

FAQ

What specific listing rule or standard has Renovaro Inc. failed to satisfy?

The filing does not specify the exact rule or standard that Renovaro Inc. has failed to satisfy, only that it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard'.

What is the potential consequence of failing to satisfy a continued listing rule?

The potential consequence is delisting from the stock exchange where the company's securities are traded.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on August 6, 2025.

What were Renovaro Inc.'s previous company names?

Renovaro Inc. was formerly known as Renovaro Biosciences Inc. and Enochian Biosciences Inc.

What is the SIC code for Renovaro Inc.?

The Standard Industrial Classification (SIC) code for Renovaro Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on August 6, 2025 regarding RENOVARO INC. (LNAI).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.